Trading For This Specialty Pharma Company is up Following Second Quarter Results
10 Agosto 2023 - 5:00PM
AllPennyStocks.com
This stock is almost a penny stock no longer, as shares moved
close to the $5 threshold following the firm’s quarterly
announcement. Leading pan-American (ex-US) specialty pharmaceutical
firm...
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni Knight Therapeutics (TSX:GUD)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Knight Therapeutics (TSX:GUD)
Storico
Da Mag 2023 a Mag 2024
